Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_assertion type Assertion NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_head.
- NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_assertion wasGeneratedBy ECO_0000203 NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_provenance.
- NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_assertion wasDerivedFrom befree-2016 NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_provenance.
- NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_assertion SIO_000772 21403679 NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_provenance.
- NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_assertion evidence source_evidence_literature NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_provenance.
- NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_assertion description "[Therapeutic targeting of Oct4(+)/TNC(+) progenitors may counteract the contribution of NB-derived ECs to tumor relapse and chemoresistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879515.RADeFUOhm89QfIZ8l2hDuXLZIx906awQz0okyGemKNMVc130_provenance.